Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer
Clinical trial NCT07490210 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07490210
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2032-05-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.